Phenomix Corporation News
Most Popular Phenomix Corporation Story
Phenomix forges $191M pact for diabetes drug
San Diego-based Phenomix is getting a $28 million injection from Italy's Chiesi Farmaceutici in exchange for a commercialization deal for the diabetes drug dutogliptin (PHX1149) in Europe and several... Read more...
Latest Headlines
- December 2, 2009
- October 23, 2008
- January 28, 2008
- January 28, 2008
- March 7, 2007
- May 23, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
